Clinical Research Directory

Inclusion Criteria: * Gestational Diabetes Mellitus (GDM) diagnosis by 1- or 2-step Oral Glucose Tolerance Test (OGTT) during pregnancy or \>= 200 mg following any glucose challenge (50g, 75g, 100g) * Has a smart phone compatible to support Dexcom Stelo app * Able to read, write, and understand English * Meet Stelo Glucose Biosensor Indications for Use (IFU) per approved commercial labeling * Willing to follow all study procedures Exclusion Criteria: * Greater than 6 weeks and 6 days postpartum at enrollment * Preexisting Type 1 Diabetes (T1D) or Type 2 Diabetes (T2D) * End-stage renal failure (on dialysis) * Heart failure * Other uncontrolled high-risk condition as determined exclusionary by site investigators * Extensive skin changes/diseases that preclude wearing the required system on normal skin (e.g. extensive psoriasis, recent burns or severe sunburn, extensive eczema, extensive scarring, extensive tattoos, dermatitis herpetiformis) at the proposed wear sites * Known severe allergy to medical-grade adhesives * Any condition that, in the opinion of the investigator, would interfere with their participation in the trial * Obesity surgery * Insulin use prior to discharge home from the delivery admission * Current participation in another postpartum Continuous Glucose Monitoring (CGM) or lifestyle intervention trial